CDH22
Cadherin-22
Also known as: C20orf25, CAD22_HUMAN, dJ998H6.1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UJ99
- Gene
- CDH22
- Ensembl
- ENSG00000149654
- Chromosome
- 20
- Canonical length
- 828 aa
- Protein class
- Predicted membrane proteins
OverviewNCBI Gene
This gene is a member of the cadherin superfamily. The gene product is composed of five cadherin repeat domains and a cytoplasmic tail similar to the highly conserved cytoplasmic region of classical cadherins. Expressed predominantly in the brain, this putative calcium-dependent cell adhesion protein may play an important role in morphogenesis and tissue formation in neural and non-neural cells during development and maintenance of the brain and neuroendocrine organs. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
828 residues, UniProt reviewed canonical sequence.
>Q9UJ99|CDH22
1 MRPRPEGRGL RAGVALSPAL LLLLLLPPPP TLLGRLWAAG TPSPSAPGAR QDGALGAGRV
61 KRGWVWNQFF VVEEYTGTEP LYVGKIHSDS DEGDGAIKYT ISGEGAGTIF LIDELTGDIH
121 AMERLDREQK TFYTLRAQAR DRATNRLLEP ESEFIIKVQD INDSEPRFLH GPYIGSVAEL
181 SPTGTSVMQV MASDADDPTY GSSARLVYSV LDGEHHFTVD PKTGVIRTAV PDLDRESQER
241 YEVVIQATDM AGQLGGLSGS TTVTIVVTDV NDNPPRFPQK MYQFSIQESA PIGTAVGRVK
301 AEDSDVGENT DMTYHLKDES SSGGDVFKVT TDSDTQEAII VVQKRLDFES QPVHTVILEA
361 LNKFVDPRFA DLGTFRDQAI VRVAVTDVDE PPEFRPPSGL LEVQEDAQVG SLVGVVTARD
421 PDAANRPVRY AIDRESDLDQ IFDIDADTGA IVTGKGLDRE TAGWHNITVL AMEADNHAQL
481 SRASLRIRIL DVNDNPPELA TPYEAAVCED AKPGQLIQTI SVVDRDEPQG GHRFYFRLVP
541 EAPSNPHFSL LDIQDNTAAV HTQHVGFNRQ EQDVFFLPIL VVDSGPPTLS STGTLTIRIC
601 GCDSSGTIQS CNTTAFVMAA SLSPGALIAL LVCVLILVVL VLLILTLRRH HKSHLSSDED
661 EDMRDNVIKY NDEGGGEQDT EAYDMSALRS LYDFGELKGG DGGGSAGGGA GGGSGGGAGS
721 PPQAHLPSER HSLPQGPPSP EPDFSVFRDF ISRKVALADG DLSVPPYDAF QTYAFEGADS
781 PAASLSSLHS GSSGSEQDFA YLSSWGPRFR PLAALYAGHR GDDEAQASLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CDH22 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 45 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 45 nTPM
- cerebral cortex: 19 nTPM
- amygdala: 13 nTPM
- hippocampal formation: 4.7 nTPM
- hypothalamus: 4.4 nTPM
- skin: 3.8 nTPM
Single-cell type
- brain excitatory neurons: 98 nCPM
- early spermatids: 92 nCPM
- salivary ionocytes: 77 nCPM
- corticotrophs: 56 nCPM
- late spermatids: 55 nCPM
- thymic myoid cells: 54 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 58 nTPM
- cerebral cortex: 50 nTPM
- amygdala: 40 nTPM
- basal ganglia: 28 nTPM
- white matter: 23 nTPM
- pons: 23 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.42
- gnomAD pLI
- 0.5
- gnomAD missense Z
- 2.78
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adherens junction organization
- calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules
- cell migration
- cell morphogenesis
- cell-cell adhesion mediated by cadherin
- cell-cell junction assembly
- homophilic cell adhesion via plasma membrane adhesion molecules
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CDH22 as an antibody target. Whether an autoantibody or antibody against CDH22 could matter depends on whether native CDH22 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CDH22 is annotated at the cell surface, where native CDH22 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CDH22 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...